Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis

Completed · Not applicable

Conditions studied: NF2-related Schwannomatosis

In brief

The goal of this clinical trial is to investigate the usability of auto-captioning glasses for adults diagnosed with NF2-related schwannomatosis and loss of hearing. The primary objective of the study is to determine the feasibility and acceptability of auto-captioning glasses in this population. Participants will be asked to: * Use the glasses at their discretion for 12 weeks * Report their feedback at 3 and 12 week timepoints via online surveys and remote qualitative interviews

Key facts

Study ID

NCT07420751

Run by

Massachusetts General Hospital

People needed

18

Starts

2026-02-19

Expected to finish

2026-08-06

Last updated by the study team

2026-08-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of NF2-SWN by 2022 revised criteria
• Age 18 years or older at time of consent
• Willing and able to sign informed consent
• Access to a mobile phone with current operating software (i.e., iOS 16+ or Android 12+) and an internet connection
• Does not require prescription glasses to communicate others (e.g. may use reading glasses or similar)
• Resident of the U.S.
• English-speaking

You may not qualify if…

• Current use of auto-captioning glasses

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.